Modlin, Robert L.
David Geffen School of Medicine at UCLA,
United States
2025 Rank: 8034
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 302 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8034 | 8439 |
| Total Cites | 40157 | 44668 |
| H-index | 107 | 114 |
| Hm-index | 35 | 36 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 487 | 494 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 1606 | 1701 |
| Number of Single+First+Last Authored Papers | 234 | 234 |
| Total Cites to Single+First+Last Authored Papers | 23841 | 26196 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 29276 | 30738 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.45 |
| Self-Citation Percentage |
10.10%
|
|
Modlin, Robert L.
University of California, Los Angeles,
United States
2024 Rank: 7562
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 295 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7562 | 8079 |
| Total Cites | 38348 | 42705 |
| H-index | 106 | 112 |
| Hm-index | 34 | 35 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 470 | 476 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 1549 | 1642 |
| Number of Single+First+Last Authored Papers | 231 | 231 |
| Total Cites to Single+First+Last Authored Papers | 23005 | 25308 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 27887 | 29282 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.46 |
| Self-Citation Percentage |
10.20%
|
|
Modlin, Robert L.
David Geffen School of Medicine at UCLA,
United States
2023 Rank: 6990
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 275 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6990 | 7492 |
| Total Cites | 36842 | 41087 |
| H-index | 105 | 111 |
| Hm-index | 33 | 35 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 460 | 466 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 1530 | 1623 |
| Number of Single+First+Last Authored Papers | 230 | 230 |
| Total Cites to Single+First+Last Authored Papers | 22290 | 24560 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 26700 | 28039 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.47 |
| Self-Citation Percentage |
10.33%
|
|
Modlin, Robert L.
David Geffen School of Medicine at UCLA,
United States
2022 Rank: 6483
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 254 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6483 | 6902 |
| Total Cites | 34708 | 38817 |
| H-index | 103 | 109 |
| Hm-index | 33 | 34 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 444 | 450 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 1484 | 1577 |
| Number of Single+First+Last Authored Papers | 229 | 229 |
| Total Cites to Single+First+Last Authored Papers | 21356 | 23597 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 25081 | 26356 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.47 |
| Self-Citation Percentage |
10.59%
|
|
Modlin, Robert L.
University of California, Los Angeles,
United States
2021 Rank: 6387
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 247 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6387 | 6705 |
| Total Cites | 33691 | 37701 |
| H-index | 101 | 109 |
| Hm-index | 32 | 34 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 422 | 428 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 1432 | 1523 |
| Number of Single+First+Last Authored Papers | 226 | 226 |
| Total Cites to Single+First+Last Authored Papers | 20796 | 22982 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 24334 | 25564 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.47 |
| Self-Citation Percentage |
10.64%
|
|
Modlin, Robert L.
David Geffen School of Medicine at UCLA,
United States
2020 Rank: 5790
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 231 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 5790 | 6134 |
| Total Cites | 31860 | 35725 |
| H-index | 100 | 107 |
| Hm-index | 32 | 33 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 404 | 410 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 1389 | 1477 |
| Number of Single+First+Last Authored Papers | 223 | 223 |
| Total Cites to Single+First+Last Authored Papers | 19735 | 21843 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 22841 | 24014 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.49 |
| Self-Citation Percentage |
10.82%
|
|